Early tumorigenesis in vivo imaging, scRNA-seq to functional assays
早期肿瘤发生体内成像、scRNA-seq 到功能测定
基本信息
- 批准号:10540327
- 负责人:
- 金额:$ 18.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-13 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAdoptedAdoptionAdultAutomobile DrivingBasement membraneBehaviorBenignBiological AssayCarcinomaCell Differentiation processCell FractionCell ProliferationCell SeparationCell physiologyCellsComplexDataDermisDevelopmentDistalDrug ScreeningEpidermisEpithelial CellsEventExcisionExhibitsFoundationsGene ExpressionGene Expression ProfileGenesGoalsGrowthHarvestHeterogeneityImageImaging DeviceIndividualInequalityInvadedLabelLasersLinkMaintenanceMalignant - descriptorMalignant NeoplasmsMolecularMotivationNatural HistoryNeoplasm MetastasisOncogenesOrganOutcomePathway interactionsPhasePhenotypePlayPopulationPositioning AttributeProcessProliferatingRecording of previous eventsReporterResolutionRoleRouteSkinSkin TissueSystemTestingTimeTissuesTransgenic OrganismsTumor Cell InvasionTumor Cell MigrationTumor stageVisualizationZebrafishcancer imagingcell behaviorcell typedesignexperimental studyimaging studyin vivoin vivo Modelin vivo imaginginsightmature animalmigrationneoplastic cellnon-invasive imagingnovel markerpreventsingle-cell RNA sequencingspatiotemporaltherapeutic targettranscriptometranscriptomicstumortumor growthtumor heterogeneitytumor initiationtumor microenvironmenttumor progressiontumorigenesis
项目摘要
PROJECT SUMMARY/ABSTRACT
Tumor heterogeneity, in cell behavior, cell microenvironment and gene expression, has become a hallmark of
tumor progression, and provides an important challenge in understanding cancer. For example, the adoption of
an invasive phenotype by some tumor cells is a key step as carcinomas advance from the benign tumor state.
Migration of tumor cells from the epithelial layers of the epidermis to the dermis provides tumor cell access to
the vasculature, offering a direct path for distal metastasis. Understanding how and why some cells are capable
of invading surrounding tissues is key to understanding tumor invasion, but current in vivo models of invasion do
not readily allow specific invasive cells to be recovered and studied to elucidate drivers of tumor invasion and
progression.
Our goal is to create a new pipeline for following tumorigenesis, permitting direct studies of tumor cell
diversification and invasion. This experimental pipeline is designed to offer capabilities to:
(i) track tumorigenesis longitudinally over time from the first origins of a tumor to key events such as invasion;
(ii) label and selectively purify tumor cell subsets identified in these time-course studies;
(iii) characterize individual tumor cells in isolated populations in unbiased way.
This approach would allow identification of the cellular events and developmental trajectories that accompany
tumor growth and invasiveness. Molecular correlates characterized in the key sub-fractions of the tumors can
be directly related to the event history of the cell sub-fractions, and the importance of these cellular and molecular
events can be tested through perturbation, ablation and function blocking experiments. Such a functional and
longitudinal experimental pipeline is key to creating more targeted and informative drug screening systems.
We have developed a set of transgenic zebrafish lines and imaging tools that allow repeated, non-invasive
visualization of endogenous tumor development in adult animals. This permits tumors to be tracked from their
origins, over long periods, after oncogene expression in skin epithelial cells. Our preliminary results show that
heterogeneity is present from the earliest stages of tumor formation, as only a small fraction of cells induced to
express oncogenes go on to form invasive tumors; such results provide the motivation for and the foundation for
our analyses of the emergence and elaboration of tumor heterogeneities.
Here, we propose to employ imaging and labeling of selected cell populations, in combination with single-cell
RNA-sequencing analyses, to study the cell behaviors and differentiation routes key to invasive tumor
development. We will establish an experimental pipeline by investigating: the cell-types specific to invasive
tumors (Aim 1); the key differentiation pathways leading to an invasive phenotype (Aim 2); and leveraging these
insights by functional assays (Aim 3). This pipeline will offer new insights into invasive tumor development,
supporting larger studies and the design of anti-tumor therapeutics targeting key cell subsets.
项目总结/摘要
肿瘤在细胞行为、细胞微环境和基因表达方面的异质性已成为肿瘤发生的标志。
肿瘤进展,并提供了一个重要的挑战,在了解癌症。例如,通过
一些肿瘤细胞的侵袭性表型是癌从良性肿瘤状态发展的关键步骤。
肿瘤细胞从表皮上皮层迁移到真皮,为肿瘤细胞提供了进入真皮的途径。
血管系统,为远端转移提供了直接途径。了解一些细胞如何以及为什么能够
侵袭周围组织的能力是理解肿瘤侵袭的关键,但目前的体内侵袭模型
不容易回收和研究特定的侵袭性细胞以阐明肿瘤侵袭的驱动因素,
进展
我们的目标是创建一个跟踪肿瘤发生的新管道,允许直接研究肿瘤细胞
多样化和入侵。该实验管道旨在提供以下功能:
(i)纵向跟踪肿瘤发生,从肿瘤的第一个起源到关键事件,如侵袭;
(ii)标记和选择性纯化在这些时程研究中鉴定的肿瘤细胞亚群;
(iii)以无偏的方式表征分离群体中的单个肿瘤细胞。
这种方法将允许识别伴随的细胞事件和发育轨迹
肿瘤生长和侵袭性。在肿瘤的关键亚组分中表征的分子相关物可以
与细胞亚组分的事件历史直接相关,这些细胞和分子的重要性
可以通过扰动、消融和功能阻断实验来测试事件。这样的功能和
纵向实验管道是创建更具针对性和信息量的药物筛选系统的关键。
我们已经开发了一套转基因斑马鱼品系和成像工具,
成年动物内源性肿瘤发展的可视化。这使得肿瘤可以从它们的
起源于皮肤上皮细胞中癌基因表达后的长时间。我们的初步结果显示,
从肿瘤形成的最早阶段就存在异质性,因为只有一小部分细胞被诱导为
表达的癌基因继续形成侵袭性肿瘤;这些结果为
我们对肿瘤异质性的出现和发展的分析。
在这里,我们建议采用成像和标记选定的细胞群,结合单细胞
RNA测序分析,以研究细胞行为和分化途径对侵袭性肿瘤的关键
发展我们将建立一个实验管道,通过调查:细胞类型的具体侵袭性
肿瘤(目标1);导致侵袭性表型的关键分化途径(目标2);以及利用这些
通过功能测定的见解(目标3)。这条管道将为侵入性肿瘤的发展提供新的见解,
支持更大规模的研究和设计针对关键细胞亚群的抗肿瘤疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT E FRASER其他文献
SCOTT E FRASER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT E FRASER', 18)}}的其他基金
Early tumorigenesis in vivo imaging, scRNA-seq to functional assays
早期肿瘤发生体内成像、scRNA-seq 到功能测定
- 批准号:
10355131 - 财政年份:2021
- 资助金额:
$ 18.9万 - 项目类别:
In vivo imaging of tumor heterogeneity generation from endogenous single cells
内源性单细胞肿瘤异质性产生的体内成像
- 批准号:
9178032 - 财政年份:2016
- 资助金额:
$ 18.9万 - 项目类别:
Phase Contrast OCT for Non-Invasive Imaging of Retinovascular Disease
用于视网膜血管疾病非侵入性成像的相差 OCT
- 批准号:
8523954 - 财政年份:2010
- 资助金额:
$ 18.9万 - 项目类别:
Characterization of Exudative Macular Degeneration and Diabetic Retinopathy Using
使用渗出性黄斑变性和糖尿病视网膜病变的表征
- 批准号:
8002119 - 财政年份:2010
- 资助金额:
$ 18.9万 - 项目类别:
Phase Contrast OCT for Non-Invasive Imaging of Retinovascular Disease
用于视网膜血管疾病非侵入性成像的相差 OCT
- 批准号:
8658435 - 财政年份:2010
- 资助金额:
$ 18.9万 - 项目类别:
Functional analysis of neural crest & palate: Imaging craniofacial development
神经嵴功能分析
- 批准号:
8068282 - 财政年份:2009
- 资助金额:
$ 18.9万 - 项目类别:
Functional analysis of neural crest & palate: Imaging craniofacial development
神经嵴功能分析
- 批准号:
7935339 - 财政年份:2009
- 资助金额:
$ 18.9万 - 项目类别:
Functional analysis of neural crest & palate: Imaging craniofacial development
神经嵴功能分析
- 批准号:
8460776 - 财政年份:2009
- 资助金额:
$ 18.9万 - 项目类别:
Functional analysis of neural crest & palate: Imaging craniofacial development
神经嵴功能分析
- 批准号:
8271340 - 财政年份:2009
- 资助金额:
$ 18.9万 - 项目类别:
Functional analysis of neural crest & palate: Imaging craniofacial development
神经嵴功能分析
- 批准号:
8652033 - 财政年份:2009
- 资助金额:
$ 18.9万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 18.9万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 18.9万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 18.9万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 18.9万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 18.9万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 18.9万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 18.9万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 18.9万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 18.9万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 18.9万 - 项目类别:
Research Grant